Kelfred Holdings Limited (HK:1134)
:1134
Want to see HK:1134 full AI Analyst Report?
Top Page
Kelfred Holdings Limited
(1134)
Select Model
Select Model
Rating:64Neutral
Price Target:
HK$0.37
▲(105.00% Upside)
Action:Reiterated
Date:05/09/26
The score is primarily supported by improving fundamentals (rebounding revenue, stronger cash generation, and low leverage) and a constructive technical uptrend. Offsetting this, profitability remains weak with ongoing losses and negative returns on equity, and valuation is penalized by the negative P/E and lack of dividend yield data.
Positive Factors
Revenue Rebound
A sustained top-line recovery and 31% annual revenue increase in 2025 indicate improving market traction and demand for the company's medical products. Durable revenue growth supports scale, allows fixed-cost absorption, and creates a runway for margin and operating leverage if the trend persists over multiple quarters.
Negative Factors
Persistent Losses / Negative ROE
Ongoing net losses and a materially negative return on equity indicate the firm's capital base is not generating acceptable returns. Over several quarters this undermines shareholder value, limits retained-earnings-funded growth, and increases pressure to achieve sustained profitability to justify invested capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
A sustained top-line recovery and 31% annual revenue increase in 2025 indicate improving market traction and demand for the company's medical products. Durable revenue growth supports scale, allows fixed-cost absorption, and creates a runway for margin and operating leverage if the trend persists over multiple quarters.
Read all positive factors
Kelfred Holdings Limited (1134) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$177.50M
Dividend YieldN/A
Average Volume (3M)1.70M
Price to Earnings (P/E)―
Beta (1Y)-0.36
Revenue Growth10.29%
EPS Growth30.25%
CountryHK
Employees1,025
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.03
Shares Outstanding500,000,000
10 Day Avg. Volume875,600
30 Day Avg. Volume1,696,000
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)0.83
Price to Sales (P/S)0.25
P/FCF Ratio5.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kelfred Holdings Limited Business Overview & Revenue Model
Company Description
Kelfred Holdings Limited (1134) is a diversified investment holding company based in [location]. The company operates across various sectors, including real estate development, investment, and management. Kelfred Holdings is involved in acquiring ...
Kelfred Holdings Limited Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
74
Positive
Cash Flow
68
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 500.25M | 453.58M | 393.28M | 465.43M | 434.73M |
| Gross Profit | 59.31M | 44.66M | 56.98M | 76.02M | 68.44M |
| EBITDA | 1.23M | -17.07M | 14.24M | 21.11M | 13.11M |
| Net Income | -15.12M | -21.63M | 1.39M | 9.18M | -2.14M |
Balance Sheet | |||||
| Total Assets | 282.83M | 282.93M | 264.00M | 251.90M | 268.13M |
| Cash, Cash Equivalents and Short-Term Investments | 48.00M | 27.81M | 20.33M | 46.40M | 36.93M |
| Total Debt | 8.46M | 12.56M | 15.22M | 2.01M | 4.00M |
| Total Liabilities | 134.35M | 126.49M | 80.81M | 65.32M | 81.80M |
| Stockholders Equity | 148.52M | 156.43M | 183.19M | 186.57M | 186.33M |
Cash Flow | |||||
| Free Cash Flow | 23.32M | 12.54M | -20.32M | 14.59M | -27.01M |
| Operating Cash Flow | 25.75M | 17.49M | -4.63M | 19.28M | -21.87M |
| Investing Cash Flow | -2.55M | -4.80M | -16.61M | -5.21M | -5.73M |
| Financing Cash Flow | -3.51M | -5.03M | -4.25M | -3.65M | -11.74M |
Kelfred Holdings Limited Technical Analysis
Neutral
0.18
Price Trends
0.32
Positive
0.28
Positive
0.25
Positive
Market Momentum
0.01
Positive
50.54
Neutral
54.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1134, the sentiment is Neutral. The current price of 0.18 is below the 20-day moving average (MA) of 0.35, below the 50-day MA of 0.32, and below the 200-day MA of 0.25, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 50.54 is Neutral, neither overbought nor oversold. The STOCH value of 54.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1134.
Kelfred Holdings Limited Peers Comparison
UnderperformOutperform
Sector (51)
HK:1134
Kelfred Holdings Limited
0.36
0.18
102.86%
HK:0907
Elegance Optical International Holdings Limited
0.06
-0.07
-54.81%
HK:2276
Shanghai Conant Optical Co. Ltd. Class H
45.24
16.49
57.36%
Kelfred Holdings Limited Corporate Events
Kelfred Adds Female Non-Executive Director to Nomination Committee to Boost Governance
Mar 25, 2026
Kelfred Holdings Limited has appointed non-executive director Ms. Chan Yin Wah, also known as Mrs. Kwok, as a member of its nomination committee with effect from 25 March 2026. Following the appointment, the five-member nomination committee includ...
Kelfred Announces Board Line-Up and Committee Roles
Mar 25, 2026
Kelfred Holdings Limited has announced the current composition of its board of directors, detailing the roles of executive, non-executive and independent non-executive directors, including the Kwok family members and other appointees. The company ...
Kelfred Narrows Annual Loss as Revenue and Gross Profit Rise in 2025
Mar 25, 2026
Kelfred Holdings Limited reported audited consolidated results for the year ended 31 December 2025, showing revenue rising to HK$500.3 million from HK$453.6 million, with gross profit improving to HK$59.3 million from HK$44.7 million. Despite this...
Kelfred Sets March Board Meeting to Approve 2025 Annual Results and Mull Final Dividend
Mar 10, 2026
Kelfred Holdings Limited has scheduled a board meeting for 25 March 2026 to review and approve the annual results for the year ended 31 December 2025 for the company and its subsidiaries. The board will also consider the publication of these resul...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.